Material: Crystal

Media Management Software Financial Tombstone

Slant-top oval financial tombstone commemorating the acquisition of CoreMedia, a New Jersey-based provider of media management software. The acquirer, Simpli.fi, is an ad targeting technology firm. (22AKL596)

2 Images
Side view of slant-top oval-shaped financial tombstone recognizing an acquisition by CoreMedia.

Ambulatory Surgical Centers Deal Toy

Crystal deal toy celebrating a strategic investment in Plano, Texas-based PSN Group. PSN is a system of ambulatory surgical centers (ASCs) and surgical hospitals. (22AKL495)

2 Images
Back view of crystal deal toy commemorating a strategic investment in PSN Group. The investment was made by BTG Pactual Strategic.

Water Management Services Deal Toy

Crystal deal toy marking the sale of Mexican water management services firm SOCAMEX. The company’s operations include water capturing, purification, and reuse. (22LJW122)

1 Image

Healthcare Startup Fund Tombstone

Crystal financial tombstone celebrating the launch of a fund by New York-based healthcare venture capital firm HC9 Ventures. The fund will focus on early-stage healthcare startups. (22AZH168)

2 Images
Back view of financial tombstone marking the launch of a healthcare fund by HC9 Ventures which will focus on seed and Series A investments.

Hipgnosis Songs Fund Deal Toy

Crystal deal toy marking a credit facility provided to UK-based Hipgnosis Songs Fund. HSF invests in artist’s song catalogs and other musical intellectual property rights. (22ALJ396)

2 Images
Back view of deal toy commemorating a credit facility provided for Lond-listed Hipgnosis Songs Fund.

Pill-Themed Finance Tombstone

Crystal tombstone marking the sale of a royalty for cancer drug Zejula. (22AKL516)

1 Image

London REIT Deal Toy

Crystal deal toy commemorating the acquisition of a London property by Life Sciences REIT. (22LJW094)

1 Image

Drug Royalty Acquisition Deal Toy

Crystal deal toy marking the acquisition of a royalty interest in global sales of pegcetacoplan, marketed under the brand names Empaveli and Aspavell. The drugs were developed for treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder. (22AKL517)

1 Image